Insulinotropic Potential of Moxifloxacin and Gemifloxacin: An In Vivo Rabbits Model Study Followed by Randomized Phase I Clinical Trial

It describes the importance of antibiotics Moxifloxacin and Gemifloxacin which can adversely affect a diabetic patient whose blood glucose level is already controlled with antidiabetic drugs.

If These antibiotics are given together with the antidiabetic drugs, there is risk that patient may develop severe fall in blood glucose levels which can be dangerous.

the article can be found on:

https://www.mdpi.com/2079-6382/11/2/148